[an error occurred while processing this directive]
|
|||||||||
CHM3931Medicinal chemistry(SCI)
Dr Peter Junk 6 points + Two 1-hour lectures, one 1-hour tutorial and the equivalent of 3 hours of laboratory activity per week + First Semester + Clayton + Prerequisites: 12 points of level 1 chemistry and normally 12 points of level 2 chemistry, or permission + Prohibitions: permission if completed CHM3031, CHM3042, CHM3051 or CHM3062 Synopsis: This subject focuses on several major classes of biologically and clinically important therapeutic agents. Students will study the traditional use, isolation, structural characterisation, sythesis and clinical evaluation of drugs and also be exposed to newer crystallographic, computational, combinatorial and screening methodology used in drug design and development. The subject will consist of three inter-related sections: a) drug discovery and development, b) molecular recognition and c) combinatorial chemistry and the synthesis of biological polymers. Where appropriate, guest speakers from industry and government agencies will contribute to the subject. Assessment: One 2.5 hour examination: 60% + Seminar/ Asssignments: 10% + Laboratory work and short laboratory reports: 30% |
Australian Government Requirements for International Students - CRICOS Provider Number: 00008C
Copyright © 1994-2001 Monash University - Last Date Modified: 20 June 2003 - Caution - Privacy Monash University ABN 12 377 614 012 |